How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals insiders reported 11 transactions: 2 stock sales totaling $171,102.34 and 9 stock awards with no cash value. All transactions occurred between June 17 and July 7, 2026.

Code for my BSc dissertation (University of Exeter, 2026). A ResNet-50 is trained to classify full-field mammograms from the INbreast dataset as low or high probability of malignancy. The method under ...

Batch convert RTF files into a merged PDF with a clickable Table of Contents and PDF bookmarks. This first version is Windows-oriented and uses LibreOffice or Microsoft Word for RTF-to-PDF conversion.